News
on
|
Research Feature
Through an adaptive research trial, doctors and patients from 30 U.S. study locations are working together to study if five new medications can help patients with severe asthma by altering the underlying biology of this airway disease. As Erin Routh prepares to walk in winter weather, she does more than put on a jacket, hat, and gloves. The 46-year...
|
Statement
On World Asthma Day, the National Institutes of Health reaffirms its commitment to research to improve the lives of people with asthma. More than 25 million people in the United States have asthma , including 5.1 million children, according to the Centers for Disease Control and Prevention. This chronic lung disease can reduce quality of life...
|
News Release
Updates to six key areas of asthma care focus on improving diagnosis, management and treatment The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and Clinical Immunology , represents the first updates to federal...
|
Research Feature
Might pave the way for new and improved treatments for a wide variety of respiratory diseases Maps may be great tools for helping you find your way around unfamiliar places, but in the future, a new type of map well might help save your life. Welcome to the Molecular Atlas of Lung Development Program, or LungMAP, a historic effort to help...
|
News Release
“Low eosinophil” biomarkers found in nearly three-quarters of people with mild persistent asthma A study of nearly 300 patients with mild persistent asthma found that inhaled steroids— long considered the gold standard for asthma treatment —were no more effective than placebo in nearly three-fourths of the study patients, all over age 12. Inhaled...
|
Statement
On World Asthma Day 2019, the National Institutes of Health stands with patients, families, advocates, researchers and health care professionals around the globe to raise awareness about this common chronic respiratory disease. In 2016, asthma affected 26 million Americans and nearly 340 million people worldwide, according to the Global Burden of...
|
Research Features
Here’s a sobering thought: Nearly half of Americans with severe asthma do not respond to conventional drugs, leaving them with few ways to minimize the often-debilitating symptoms of the chronic disease. But researchers at NHLBI have developed a new treatment that has the potential to dramatically change that: A synthetic peptide that mimics the...
|
Statement
On World Asthma Day 2018, the National Institutes of Health stands with people worldwide to renew our commitment to advance understanding of asthma and develop effective strategies to manage, treat and ultimately prevent the disease. A new three-minute NIH video provides a glimpse into the stories of patients and doctors who are working to advance...
|
News Release
NIH-funded findings challenge common practice of increasing doses at early signs of worsening symptoms Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups, and may be associated with slowing a child’s growth, challenging a common medical...
|
Research Features
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), has awarded four grants to improve outcomes for children in communities with especially high rates of childhood asthma. These grants—for Philadelphia, PA; Richmond, VA; the greater Providence, RI area; and in three agencies on the Navajo Nation...
|
Media Availability
WHAT: May is National Asthma and Allergy Awareness Month and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss current asthma research focused on treatment, causes and comorbidities of this condition that affects more than 24 million people in the United States, including more than six million children...
|
News Release
May is Asthma Awareness Month, and the National Institutes of Health is finding solutions to improve the health of the nearly 25 million people in the United States who currently have asthma. In recent decades, the prevalence of asthma has been increasing, resulting in millions of urgent medical visits and missed days of work and school each year...
|
Media Availability
WHAT : Scientists funded by the National Heart, Lung, and Blood Institute have shown a link between persistent childhood asthma and chronic obstructive pulmonary disease (COPD). Persistent asthma is characterized by recurrent breathing difficulties irrespective of medication use. COPD is a debilitating lung disease that typically affects current or...
|
Statement
On World Asthma Day 2016, the National Institutes of Health reaffirms its commitment to support research to improve the lives of all people with asthma. NIH-funded research has advanced our understanding of asthma as a disease as well as the impact asthma has on the lives of those affected. We have made great strides in learning how to treat and...
|
Media Availability
WHAT : Providing extra vitamin D to women during pregnancy raised their vitamin D levels without changing recurrent wheezing rates in their offspring by age 3 years, National Institutes of Health-supported research found. However, in these children, who are at high risk for developing asthma, blood tests showed lower levels of specific antibodies...
|
Research Feature
This article is the third in a three-part series about the NHLBI CADET II program. Although a variety of treatment options are available for patients with lung diseases such as asthma and chronic obstructive pulmonary disease (COPD), some patients do not respond to existing medications or experience side effects that limit the patients’ ability to...
|
Statement
On World Asthma Day 2015, the National Institutes of Health stands with the international community to renew our commitment to advance our understanding of asthma and develop effective strategies to manage and prevent the disease. Within a broad asthma research portfolio, NIH-supported scientists are making progress in understanding how certain...
|
Media Availability
WHAT: Supplementing inhaled corticosteroids (ICS) with vitamin D does not reduce the rate of treatment failure in patients with asthma and vitamin D insufficiency, finds a new National Institutes of Health-funded study. The Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) trial randomized 408 adults with low vitamin...
|
News Release
Adding the acid reflux drug lansoprazole to a standard inhaled steroid treatment for asthma does not improve asthma control in children who have no symptom of acid reflux, according to a new study funded in part by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. Lansoprazole therapy slightly...